Kyphoplasty denied due to quantity / dose limits by Medicare?

Medicare's specific coverage criteria for kyphoplasty are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Medicare Denied This Claim: Quantity Limits

Medicare and its contractors apply coverage limitations on vertebral augmentation procedures — including balloon kyphoplasty — that address how many vertebral levels or sessions may be covered under a single course of treatment. A "quantity limits" denial typically means the claim exceeded the number of levels, sessions, or procedures specified in the applicable Local Coverage Determination (LCD). This denial is appealable when additional levels or sessions are clinically justified by the patient's specific fracture pattern, pain burden, and functional status.

## Your Federal Appeal Rights

Medicare's five-level administrative appeal process protects your right to challenge this denial:

• Level 1 — Redetermination with the Medicare Administrative Contractor (MAC): file within 120 days of the denial.
• Level 2 — Reconsideration with a Qualified Independent Contractor (QIC): file within 180 days of the redetermination.
• Levels 3–5 — ALJ hearing, Medicare Appeals Council, Federal District Court.
• Expedited track — available when the standard timeline would seriously jeopardize your health or function.

File dates and mailing addresses appear on your Medicare Summary Notice (MSN) or Explanation of Benefits (EOB).

## Why This Is Worth Appealing

LCDs set default quantity parameters, but they also contain provisions for exceptions when additional levels are clinically necessary. If a patient sustained fractures at multiple adjacent levels simultaneously, or if a second procedure was required because a new acute fracture occurred after an initial procedure, the clinical circumstances may fall within a recognized exception — or may justify a formal medical-necessity exception request at the appeal level.

## Documentation to Gather

1. Imaging for each treated level — separate radiology reports (CT or MRI) confirming each fracture, its level, its acuity (acute vs. chronic), and the date it was identified. 2. Operative report — detail on how many levels were treated, in which session(s), and the clinical rationale for treating multiple levels. 3. Clinical severity documentation — pain scores, functional assessments, and neurological findings documented in the chart for each affected level. 4. Timeline of fractures — evidence showing whether multiple fractures were simultaneous (single traumatic event) or sequential (separate events), which affects the quantity-limit analysis. 5. Prescriber medical-necessity letter — the treating surgeon must explain, level by level, why each treated vertebra was independently indicated and why a single-level approach would have been clinically insufficient. 6. Applicable LCD — obtain the current MAC LCD for vertebral augmentation. Identify the quantity limit provision and any exception language, then map each exception criterion to your chart evidence.

## Criteria-Mapping Structure

| LCD Quantity Parameter | How Your Case Differs | |---|---| | Standard covered number of levels | Number of levels treated and clinical reason | | Acute fracture timing requirement | Imaging dates establishing acuity at each level | | Exception criterion (if stated in LCD) | Specific chart fact satisfying that criterion | | Independent clinical indication per level | Surgeon attestation per level |

A well-structured appeal that addresses each level independently — rather than arguing globally — gives reviewers the granular justification they need to approve an exception.